Trials / Completed
CompletedNCT02704559
Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, oral dose, crossover study to explore drug-drug interactions between DWC20155 and DWC20156 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWC20155 | |
| DRUG | DWC20156 |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2016-03-10
- Last updated
- 2017-02-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02704559. Inclusion in this directory is not an endorsement.